Re-examine JnJ baby powder samples: HC directs Maharashtra govt
"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution,” the court said.
Advertisement
Mumbai: The Bombay High Court on Monday directed the Maharashtra government to re-examine samples of baby powder manufactured by Johnson & Johnson Pvt Ltd in government or government-approved laboratories.
A division bench of Justices S V Gangapurwala and S G Dige asked additional government leader Milind More to submit names on November 16 of such labs where the tests can be conducted.
The order was passed while hearing a petition filed by the company challenging two orders of the state government, one dated September 15 cancelling the licence and the second dated September 20 ordering an immediate stop to the manufacturing and sale of the company's baby powder product.
The orders were passed by the Joint Commissioner and Licensing Authority of the state Food and Drug Administration (FDA).
The state government had based its orders on the report of the Central Drug Laboratory, which found the powder contained higher pH level than prescribed.
The HC, on Monday, also asked the state to take instructions on whether they would be willing to allow the company to begin manufacturing of the powder at the facility.
"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution," the court said.
The company, in its plea, said 14 random batches of February, March, and September 2022 were tested by an independent public testing laboratory and all were found to be well within the prescribed pH value.
The leading fast-moving consumer goods (FMCG) manufacturer said it has been making baby powder in its Mulund plant for the last 57 years and its licence was renewed in January 2020. The company said it was facing a daily loss of Rs 2.5 crore, based on market value of goods sold, due to revocation of licence.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.